Release Date: 26/11/13 13:42 Summary: Expiry of Unlisted Options Price Sensitive: No Download Document 326.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%